Celltrion
068270.KS
#771
Rank
A$43.40 B
Marketcap
A$198.40
Share price
1.48%
Change (1 day)
5.18%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2025 (TTM): A$1.30 Billion

According to Celltrion 's latest financial reports the company's current earnings are A$2.94 Billion. , an increase over its 2024 earnings that were of A$0.67 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2025

Annual earnings

Year Earnings Change
2025 A$1.25 B84.38%
2024 A$0.67 B-8.89%
2023 A$0.74 B6.61%
2022 A$0.69 B-21.93%
2021 A$0.89 B10.28%
2020 A$0.81 B65.38%
2019 A$0.49 B16.74%
2018 A$0.42 B-33.93%
2017 A$0.63 B106.65%
2016 A$0.30 B25.18%
2015 A$0.24 B-6.4%
2014 A$0.26 B47.49%
2013 A$0.17 B-33.58%
2012 A$0.26 B
2010 A$0.13 B72.52%
2009 A$81.04 M258.3%
2008 A$22.61 M